Eleva is a biopharmaceutical company discovering and developing previously inaccessible biological therapeutics. Our clinical-stage, first-in-class Factor H (CPV-104) program aims to bring the benefits of precision complement modulation to patients suffering from severe kidney disorders, dry AMD and other complement-driven diseases. Beyond CPV-104, our mission is to establish a broad pipeline of unique product candidates that benefit from our moss-based technology and expertise in enabling next-generation medicines.
| Website | http://www.elevabiologics.com |
| Employees | 87 (34 on RocketReach) |
| Founded | 1999 |
| Technologies |
JavaScript
,
HTML
,
PHP
+26 more
(view full list)
|
| Industry | Biotechnology |
| Keywords | Biopharmaceutical, Biologics, Drug Development, Clinical Stage, Manufacturing Platform, Enzyme Replacement Therapy, Therapeutic Proteins, Breakthrough Technology, Pharmaceutical Manufacturing, Biotechnology, Drug Discovery, Protein Engineering, Process Development, Clinical Trials, Rare Diseases, Genetic Disorders, Bioprocessing, Pharmaceutical Research |
| Competitors | Novartis, Merck AH, AbbVie, Sanofi, Genentech, Regeneron, Gilead Sciences, Amgen, Biogen, Mylan Belgium +37 more (view full list) |
Looking for a particular eleva employee's phone or email?
Donato Spota is the CFO of eleva.
34 people are employed at eleva.